Your browser doesn't support javascript.
loading
[Anaplastic lymphoma kinase-translocation renal cell carcinoma: clinical and pathological analysis].
Di, S H; Wang, X T; Xia, Q Y; Lu, Z F; Ma, H H; Zhang, R S; Wang, X; Rao, Q.
Afiliação
  • Di SH; Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.
  • Wang XT; Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.
  • Xia QY; Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.
  • Lu ZF; Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.
  • Ma HH; Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.
  • Zhang RS; Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.
  • Wang X; Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.
  • Rao Q; Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.
Zhonghua Bing Li Xue Za Zhi ; 51(1): 28-32, 2022 Jan 08.
Article em Zh | MEDLINE | ID: mdl-34979750

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: Zh Revista: Zhonghua Bing Li Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: Zh Revista: Zhonghua Bing Li Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China